A detailed history of Acropolis Investment Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Acropolis Investment Management, LLC holds 1,017 shares of AMGN stock, worth $299,537. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,017
Previous 1,017 -0.0%
Holding current value
$299,537
Previous $327,000 -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$262.75 - $319.31 $4,729 - $5,747
18 Added 1.8%
1,017 $317,000
Q4 2023

Jan 16, 2024

BUY
$255.7 - $288.46 $8,693 - $9,807
34 Added 3.52%
999 $287,000
Q3 2023

Oct 11, 2023

BUY
$218.65 - $271.46 $655 - $814
3 Added 0.31%
965 $259,000
Q2 2023

Jul 13, 2023

SELL
$214.27 - $253.37 $3,214 - $3,800
-15 Reduced 1.54%
962 $213,000
Q1 2023

Apr 11, 2023

SELL
$225.79 - $275.2 $903 - $1,100
-4 Reduced 0.41%
977 $236,000
Q4 2022

Jan 11, 2023

BUY
$229.03 - $291.01 $3,435 - $4,365
15 Added 1.55%
981 $0
Q3 2022

Oct 12, 2022

SELL
$224.46 - $253.15 $3,591 - $4,050
-16 Reduced 1.63%
966 $218,000
Q2 2022

Jul 15, 2022

BUY
$230.71 - $256.74 $3,691 - $4,107
16 Added 1.66%
982 $239,000
Q1 2022

Apr 08, 2022

SELL
$219.27 - $242.57 $21,927 - $24,257
-100 Reduced 9.38%
966 $234,000
Q4 2021

Jan 14, 2022

BUY
$198.88 - $227.6 $2,983 - $3,414
15 Added 1.43%
1,066 $240,000
Q3 2021

Oct 12, 2021

SELL
$212.27 - $248.7 $4,245 - $4,974
-20 Reduced 1.87%
1,051 $223,000
Q1 2021

Apr 12, 2021

SELL
$221.91 - $258.6 $1,331 - $1,551
-6 Reduced 0.56%
1,071 $266,000
Q4 2020

Jan 13, 2021

BUY
$216.38 - $257.67 $18,608 - $22,159
86 Added 8.68%
1,077 $248,000
Q2 2020

Jul 15, 2020

BUY
$197.81 - $242.74 $3,164 - $3,883
16 Added 1.64%
991 $234,000
Q1 2020

Apr 10, 2020

BUY
$182.24 - $241.7 $177,684 - $235,657
975 New
975 $198,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Acropolis Investment Management, LLC Portfolio

Follow Acropolis Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acropolis Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acropolis Investment Management, LLC with notifications on news.